Foamy virus pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production

Journal of Virology

Volumn 86, Issue 11, 2012, Pages 5992-6001

  Lee, Eun Gyung ^a   Sinicrope, Amber ^a,b   Jackson, Dana L ^a   Yu, Shuyuarn F ^a   Linial, Maxine L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Pacific Northwest University of Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GENOMIC RNA; HYBRID PROTEIN; INTEGRASE; MESSENGER RNA; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME; VIROSOME;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPUMA VIRUS; STRUCTURAL GENE; VIRION; VIRUS ASSEMBLY; VIRUS GENE; VIRUS INFECTIVITY; VIRUS LIKE AGENT; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TITRATION; WILD TYPE; ANIMAL; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOGENICITY; RNA SPLICING; ULTRASTRUCTURE;

HUMAN SPUMARETROVIRUS;

ANIMALS; GENE EXPRESSION; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; HUMANS; RECOMBINANT FUSION PROTEINS; RNA SPLICING; SPUMAVIRUS; VIRION; VIROSOMES;

EID: 84863589119     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06979-11     Document Type: Article

References (41)

1. Baldwin DN, Linial ML. 1998. The roles of Pol and Env in the assembly pathway of human foamy virus. J. Virol. 72:3658-3665.
2. Baldwin DN, Linial ML. 1999. Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles. J. Virol. 73:6387-6393.
3. Duda A, et al. 2004. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 78:13865-13870.
4. Durocher Y, Perret S, Kamen A. 2002. High-level and high-throughput recombinant protein production by transient transfection of suspensiongrowing human 293-EBNA1 cells. Nucleic Acids Res. 30:e9.
5. Eastman SW, Linial ML. 2001. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J. Virol. 75: 6857-6864.
6. Enssle J, et al. 1997. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J. Virol. 71:7312-7317.
7. Felsenstein KM, Goff SP. 1988. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J. Virol. 62:2179-2182.
8. Fischer N, et al. 1998. Foamy virus particle formation. J. Virol. 72:1610-1615.
9. Goff SP. 2007. Retroviridae: the retroviruses and their replication, p 1999-2069. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Williams and Wilkins, Philadelphia, PA.
10. Haraguchi H, et al. 2010. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio. Microbiol. Immunol. 54:734-746.
11. Hartl MJ, et al. 2010. Formation of transient dimers by a retroviral protease. Biochem. J. 427:197-203.
12. Heinkelein M, et al. 2002. Pregenomic RNA is required for efficient incorporation of Pol polyprotein into foamy virus capsids. J. Virol. 76: 10069-10073.
13. Jewell NA, Mansky LM. 2000. In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J. Gen. Virol. 81:1889-1899.
14. Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B. 1993. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193:661-671.
15. Lee E-G, et al. 2008. A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA. J. Virol. 82:1656-1664.
16. Lee E-G, Linial ML. 2006. Deletion of a Cys-His motif from the Alpharetrovirus nucleocapsid domain reveals late domain mutant-like budding defects. Virology 347:226-233.
17. Lee E-G, Linial ML. 2008. The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions. J. Virol. 82:10803-10810.
18. Lee E-G, et al. 2011. Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation. J. Virol. 85:1655-1661.
19. Löchelt M, Flügel RM. 1996. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J. Virol. 70:1033-1040.
20. Mullers E, et al. 2011. Novel functions of prototype foamy virus Gag glycine-arginine-rich boxes in reverse transcription and particle morphogenesis. J. Virol. 85:1452-1463.
21. Muriaux D, Mirro J, Harvin D, Rein A. 2001. RNA is a structural element in retrovirus particles. Proc. Natl. Acad. Sci. U. S. A. 98:5246-5251.
22. Park J, Morrow CD. 1991. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65:5111-5117.
23. Park J, Morrow CD. 1992. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
24. Peters K, Wiktorowicz T, Heinkelein M, Rethwilm A. 2005. RNA and protein requirements for incorporation of the Pol protein into foamy virus particles. J. Virol. 79:7005-7013.
25. Pettit SC, Everitt LE, Choudhury S, Dunn BM, Kaplan AH. 2004. Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J. Virol. 78:8477-8485.
26. Pfrepper KI, et al. 1998. Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J. Virol. 72:7648-7652.
27. Roy J, Linial ML. 2007. Role of the foamy virus Pol cleavage site in viral replication. J. Virol. 81:4956-4962.
28. Rulli SJ, Jr, et al. 2007. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J. Virol. 81:6623-6631.
29. Shehu-Xhilaga M, Crowe SM, Mak J. 2001. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75:1834-1841.
30. Smith AJ, Srinivasakumar N, Hammarskjold M-L, Rekosh D. 1993. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into particles. J. Virol. 67:2266-2275.
31. Stenbak CR, Linial ML. 2004. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J. Virol. 78:9423-9430.
32. Stirnnagel K, et al. 2010. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7:45.
33. Swiersy A, Wiek C, Reh J, Zentgraf H, Lindemann D. 2011. Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication. Retrovirology 8:66.
34. Tobaly-Tapiero J, et al. 2000. Isolation and characterization of an equine foamy virus. J. Virol. 74:4064-4073.
35. Weaver TA, Talbot KJ, Panganiban AT. 1990. Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J. Virol. 64:2642-2652.
36. Winkler I, et al. 1997. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 71:6727-6741.
37. Wlodawer A, et al. 1989. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 245:616-621.
38. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. 1996. Human foamy virus replication-a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
39. Yu SF, Linial ML. 1993. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J. Virol. 67:6618-6624.
40. Yu SF, Eastman SW, Linial ML. 2006. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 7:966-977.
41. Zemba M, et al. 1998. The carboxy-terminal p3(Gag) domain of the human foamy virus gag precursor is required for efficient virus infectivity. Virology 247:7-13.